News | Artificial Intelligence | August 18, 2022

CardioWise, Inc. Selected for the Inaugural Edison Accelerator By GE Healthcare in Collaboration with Nex Cubed

Six digital healthcare start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program orchestrated by GE Healthcare.

August 18, 2022 — Six digital healthcare start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program orchestrated by GE Healthcare

The selected companies all focus on applying Artificial Intelligence (AI) to augment medical imaging with the potential to transform how healthcare is delivered. AI is poised to increase productivity and the efficiency of care delivery and allow healthcare systems to provide better care to more people. AI can help improve healthcare practitioners' experience, enabling them to spend more time in direct patient care and reducing costs. 

CardioWise SQuEEZ Software is an image analysis software application for cardiac Computed Tomography (CT) studies to assist cardiologists and radiologists in assessing heart function. The software calculates a Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ) value to highlight and color code abnormalities in the wall motions of the heart. The cloud-based Software as a Service analysis is an intuitive, quantitative method to classify LV contractile function that has the potential to provide significant improvement in clinical decision-making relative to the inconsistent, qualitative tests used today. 

Over the next three months, the chosen companies will integrate their solution within the Edison Digital Health Platform, which takes a vendor-agnostic approach to developing and deploying Artificial Intelligence solutions integrated within their clinical and operational workflow platforms. Each company has a customized program plan with the aim to accelerate integration and commercialization. The program culminates with an Innovation Showcase, during which all participants will present to a network of investors, potential business partners and customers who could help take their companies to the next level. 

CardioWise has received the applicable regulatory clearances, including the FDA 510(k) and ISO 13485, necessary for distribution in the USA and the European Union. After the successful integration and term sheet agreements with GE, CardioWise will have the opportunity to distribute its products through the GE Healthcare Edison Marketplace. This marketplace is GE Healthcare’s online store that allows customers to find and buy the CardioWise applications that have been successfully integrated directly into the GE clinical and operational workflows to help healthcare providers improve patient care. 

Jack Coats, CEO of CardioWise said, “We are very pleased to have been chosen to participate in the first cohort of the Edison Accelerator in Canada by GE Healthcare and Nex Cubed to accelerate CardioWise SQuEEZ AI cardiac functional analysis that provides a quantitative evaluation of heart function. CardioWise SQuEEZ analysis can provide caregivers with an easy-to-read, quantitative 4D color model that allows physicians to make better, more informed decisions about their patient’s care.” 

 

For more information: https://www.cardiowiseinc.com/ 


Related Content

News | Computed Tomography (CT)

August 31, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), fully automated and normalized body ...

Home August 31, 2022
Home
News | Computed Tomography (CT)

August 15, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), the combination of deep-learning ...

Home August 15, 2022
Home
News | Computed Tomography (CT)

June 16, 2022 — Xoran Technologies has recently received a patent for a modular computed tomography (CT) system assembly ...

Home June 16, 2022
Home
News | Computed Tomography (CT)

June 15, 2022 — Seven finalists have been selected for the Best Abstract Award in cardiovascular computed tomography ...

Home June 15, 2022
Home
News | Computed Tomography (CT)
March 29, 2022 – Cardiac computed tomography (CCT) is an accurate, noninvasive diagnostic test for obstructive coronary ...
Home March 29, 2022
Home
News | Computed Tomography (CT)
March 11, 2022 – Is cardiac computed tomography (CT) as reliable as catheterization in patients with suspected coronary ...
Home March 11, 2022
Home
News | Computed Tomography (CT)

January 31, 2022 — Lee Health’s Gulf Coast Medical Center in Fort Myers, Fla., recently became the first U.S. healthcare ...

Home January 31, 2022
Home
News | Computed Tomography (CT)

October 20, 2021 — HeartFlow Inc. announced the commencement of the REVEALPLAQUE (A pRospEctiVe, multicEnter study to ...

Home October 20, 2021
Home
News | Computed Tomography (CT)

October 14, 2021 — Cardiac computed tomography angiography (CTA) derived left atrium emptying fraction (LAEF) improves ...

Home October 14, 2021
Home
Feature | Computed Tomography (CT)

October 6, 2021 — Data presented during the late-breaking science session at the European Society of Cardiology (ESC) ...

Home October 06, 2021
Home
Subscribe Now